Pfizer Wins Further Drug Approval, Wells Fargo Buys U.K. Real Estate Assets, and 3 More Hot Stocks

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Pfizer Inc. (NYSE:PFE): Pfizer’s Tofacitinib treatment for rheumatoid arthritis has won approval in Switzerland, joining Argentina, Kuwait, the United Arab Emirates, the U.S., Japan, and Russia to grant the drug approval. The drug can be used in patients who did not respond as well to other treatments. Tofacitinib is expected to be rolled out domestically this month, in conjunction with Takeda.


More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business